EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.
|
29432562 |
2018 |
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.
|
29432562 |
2018 |
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.
|
28942967 |
2017 |
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.
|
28942967 |
2017 |
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.
|
29432562 |
2018 |
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Malignant neoplasm of prostate
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
CONCLUSIONS In prostate cancer, miR-99a-3p expression was associated with the Wnt and VEGF signaling pathways, which might inhibit the expression of PPP3CA or HYOU1.
|
29997385 |
2018 |
Malignant neoplasm of prostate
|
0.310 |
Biomarker
|
disease |
CTD_human |
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
|
17199135 |
2007 |
Carcinoma, Ovarian Epithelial
|
0.300 |
Biomarker
|
disease |
CTD_human |
Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
|
30365097 |
2019 |
Adenocarcinoma of lung (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
New significantly mutated genes included PPP3CA, DOT1L, and FTSJD1 in lung ADC, RASA1 in lung SqCC, and KLF5, EP300, and CREBBP in both tumor types.
|
27158780 |
2016 |
Hepatolenticular Degeneration
|
0.300 |
Biomarker
|
disease |
CTD_human |
The early molecular processes underlying the neurological manifestations of an animal model of Wilson's disease.
|
23519153 |
2013 |
Hepatic Form of Wilson Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
The early molecular processes underlying the neurological manifestations of an animal model of Wilson's disease.
|
23519153 |
2013 |
Pancreatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Exocrine pancreatic carcinogenesis and autotaxin expression.
|
22952646 |
2012 |
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
|
17199135 |
2007 |
Testicular Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
FK506, a calcineurin inhibitor, prevents cadmium-induced testicular toxicity in mice.
|
17785681 |
2007 |
Left Ventricular Hypertrophy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats.
|
18344631 |
2007 |
Kidney Diseases
|
0.200 |
Biomarker
|
group |
RGD |
Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm.
|
27009276 |
2016 |
Right Ventricular Hypertrophy
|
0.200 |
Biomarker
|
disease |
RGD |
Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy.
|
16799071 |
2006 |
Reperfusion Injury
|
0.200 |
Biomarker
|
disease |
RGD |
Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion.
|
14762344 |
2004 |
Cardiomyopathy, Dilated
|
0.200 |
Biomarker
|
group |
MGD |
|
|
|
Dwarfism
|
0.110 |
Biomarker
|
disease |
BEFREE |
The expression level of three candidate genes, <i>ADAMTS like 1</i>, <i>Larp7</i> and <i>PPP3CA,</i> were significantly different between the dwarf and normal sailfin mollies in the hepatopancreas, with <i>PPP3CA</i> also showing significant differences in the vertebrae and <i>Larp7</i> showing significant differences in the muscle.
|
31151300 |
2019 |
Epileptic encephalopathy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
We describe a boy with similar phenotype and severe early onset epileptic encephalopathy in whom a novel de novo c.1324C>T (p.(Gln442Ter)) PPP3CA variant was found by whole exome sequencing.
|
30254215 |
2019 |
Seizures
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.
|
28942967 |
2017 |